# Stericycle

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stericycle

- Industry: Power & Utilities
- Headquarters: US
- Website: www.stericycle.com
- Total disclosed funding: $7.1M
- Latest round: Seed (Apr 4, 1989)
- Investors on record: 2

## About

Stericycle, Inc. provides essential waste management solutions, specializing in regulated medical waste disposal, sharps disposal, and pharmaceutical waste management for healthcare clients while ensuring compliance with safety regulations.Founded in 1989 in the US, Stericycle, Inc. specializes in waste management for healthcare providers. The company has not undergone significant pivots but continues to expand its service offerings. Its current CEO is Andrew Pooley, and notable founders include Jagdeep Singh, Matteo Ventimiglia, Mohammed Athambawa, Mutaz Khalifa, Nguyen Le. Stericycle successfully raised USD 75.00 mn in a PIPE funding round with investors Bain Capital and Madison Dearborn Partners, bringing its total amount raised to USD 75.00 mn. The company has completed six deals, with its most recent deal dating back to August 23, 1996.Stericycle specializes in providing comprehensive waste management solutions, focusing primarily on regulated medical waste disposal, sharps disposal, and pharmaceutical waste management. Their core offerings include the compliant transportation, treatment, and disposal of medical waste while prioritizing safety through reusable and disposable sharps containers that mitigate needlestick injuries. The company also provides compliance-based solutions, including pharmaceutical waste disposal, to help healthcare providers efficiently manage hazardous waste and adhere to regulatory standards. Their customer base includes a diverse range of clients such as hospitals, healthcare systems, nursing facilities, and outpatient surgery centers across North America, Europe, and select international markets. Stericycle's services address critical health and safety concerns while supporting sustainability goals through innovative waste management practices.Stericycle generates revenue of USD 2.66 bn in 2023, with an EBITDA of USD 293.80 mn. The company’s structured model encompasses a variety of service contracts with its clients, primarily in the healthcare sector. Transactions typically involve long-term service agreements, ensuring consistent waste disposal services. Clients receive tailored waste management services that meet regulatory requirements while reducing operational risks. Flagship services, including regulated medical waste disposal and pharmaceutical waste management, underpin their revenue streams, reflecting the essential nature of these solutions in maintaining health and safety standards.Stericycle plans to enhance its service portfolio with the introduction of new waste management technologies and compliance solutions in the near future. The company is focusing on expanding its operations into emerging markets in Asia and Latin America, aiming for significant market penetration by 2026. The recent funding of USD 75.00 mn will be allocated towards these initiatives, supporting product development, market entry strategies, and strengthening operational capabilities to meet the evolving needs of healthcare providers.

## Funding rounds

- Seed, Apr 4, 1989, $7.1M — Marquette Venture Partners, State Farm Ventures

## Investors

- Marquette Venture Partners (https://capitalatlas.ai/funds/marquette-venture-partners) — Seed
- State Farm Ventures (https://capitalatlas.ai/funds/state-farm-ventures) — Seed